CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Large B-cell Lymphoma

Conditions: Lymphoma, Non-Hodgkin; Diffuse Large B Cell Lymphoma Interventions: Biological: CD19-targeted Chimeric Antigen Receptor(CAR) T Cells Sponsors: Shanghai Ming Ju Biotechnology Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials